Impact of the Platelet-to-Lymphocyte Ratio as a Biomarker for Esophageal Squamous Cell Carcinoma

被引：8
作者：
Kato, Takashi [1 ]
Oshikiri, Taro [1 ]
Goto, Hironobu [1 ]
Sawada, Ryuichiro [1 ]
Harada, Hitoshi [1 ]
Urakawa, Naoki [1 ]
Hasegawa, Hiroshi [1 ]
Kanaji, Shingo [1 ]
Yamashita, Kimihiro [1 ]
Matsuda, Takeru [2 ]
Kakeji, Yoshihiro [1 ]
机构：
[1] Kobe Univ, Grad Sch Med, Dept Surg, Div Gastrointestinal Surg, Kobe, Hyogo, Japan
[2] Kobe Univ, Grad Sch Med, Dept Surg, Div Minimally Invas Surg, Kobe, Hyogo, Japan
来源：
ANTICANCER RESEARCH | 2022年 / 42卷 / 05期
关键词：
Biomarker; esophageal squamous cell carcinoma; platelet-to-lymphocyte ratio; RECURRENT LARYNGEAL NERVE; CHARACTERISTIC ROC CURVE; LAPAROSCOPIC SURGERY; CANCER; LYMPHADENECTOMY; INFLAMMATION; LEUKOCYTE; SURVIVAL; OUTCOMES;
D O I：
10.21873/anticanres.15757
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background/Aim: Esophageal squamous cell carcinoma (ESCC) is a deadly malignant disease. This study examined whether the platelet-to-lymphocyte ratio (PLR) can be used as a biomarker to evaluate prognosis in patients with advanced ESCC following neoadjuvant chemotherapy (NAC) and undergoing minimally invasive esophagectomy (MIE). Patients and Methods: We examined 174 patients between January 2010 and December 2015 at the Kobe University. Of these, 121 were treated with NAC. The PLR cutoff was determined through receiver-operating characteristic curve analysis. Univariate and multivariate analyses were conducted to identify prognostic factors for overall survival (OS). Results: The PLR cutoff for OS in 121 patients was 169.6. Patients with PLR 169.6 (61.1%, p=0.001). Multivariate analysis revealed that a PLR of 169.6 was an independent factor for poor prognosis. Conclusion: PLR is an independent prognostic factor for patients with ESCC after NAC and MIE.
引用
收藏
页码：2775 / 2782
页数：8
相关论文
共 50 条
  • [41] Assessment of the Clinical Value of Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma
    Chen, Xu
    Mohammed, Abdul Fatawu
    Li, Chengbin
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2024, 30
  • [42] Is assessment of platelet-lymphocyte ratio and neutrophil-lymphocyte ratio a predictor for lymph node metastasis in oral squamous cell carcinoma?
    Uniyal, Akanksha
    Urs, Aadithya B.
    Augustine, Jeyaseelan
    Khurana, Neeta
    Passey, J. C.
    Meher, Ravi
    INDIAN JOURNAL OF CANCER, 2024, 61 (03) : 516 - 522
  • [43] Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as predictive biomarkers for treatment response in primary advanced hypopharyngeal squamous cell carcinoma treated with chemoimmunotherapy
    Yueyue Shi
    Xueyan Zhao
    Yan Zhou
    Xiaomeng Zhang
    Clinical and Experimental Medicine, 25 (1)
  • [44] Neutrophil-to-lymphocyte ratio after neoadjuvant chemotherapy as an independent prognostic factor in patients with esophageal squamous cell carcinoma
    Yamada, Moyuru
    Tanaka, Koji
    Yamasaki, Makoto
    Yamashita, Kotaro
    Makino, Tomoki
    Saito, Takuro
    Takahashi, Tsuyoshi
    Kurokawa, Yukinori
    Motoori, Masaaki
    Kimura, Yutaka
    Nakajima, Kiyokazu
    Eguchi, Hidetoshi
    Doki, Yuichiro
    ONCOLOGY LETTERS, 2023, 25 (02)
  • [45] Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio during immune checkpoint inhibitor treatment in recurrent or metastatic head and neck squamous cell carcinoma patients
    Li, Jun-Liang
    Hsieh, Tsai-Ling
    Ou, Ming-Che
    Lin, Frank Cheau-Feng
    Tsai, Stella Chin-Shaw
    ORAL ONCOLOGY, 2022, 126
  • [46] The prognostic roles of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in gastrointestinal stromal tumours: a meta-analysis
    Wei, Zhe-Wei
    Huang, Wei-Bin
    Yang, Dong-Jie
    Yuan, Yu-Jie
    He, Yu-Long
    Zhang, Chang-Hua
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (09) : 5128 - +
  • [47] Prognostic role of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with bone metastases
    Thio, Quirina C. B. S.
    Goudriaan, W. Alexander
    Janssen, Stein J.
    Pereira, Nuno Rui Paulino
    Sciubba, Daniel M.
    Rosovksy, Rachel P.
    Schwab, Joseph H.
    BRITISH JOURNAL OF CANCER, 2018, 119 (06) : 737 - 743
  • [48] Prognostic significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio in uterine carcinosarcoma
    Sakurai, Azusa
    Yamaguchi, Ken
    Ishida, Kentaro
    Horikawa, Naoki
    Kawai, Eri
    Kotani, Yasushi
    Yoshida, Takaaki
    Kishimoto, Naoya
    Tatsumi, Keiji
    Okudate, Minami
    Iemura, Yoko
    Taga, Yukiko
    Aki, Megumi
    Ando, Yukiko
    Yanai, Akihiro
    Yamanoi, Koji
    Taki, Mana
    Murakami, Ryusuke
    Hamanishi, Junzo
    Mandai, Masaki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2025, 30 (03) : 570 - 583
  • [49] Associations between neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio and prognosis in patients with neuroblastoma
    Mirzayeva, Gunay
    Kupeli, Serhan
    Ozkan, Ayse
    Sezgin, Gulay
    Bayram, Ibrahim
    PEDIATRIC BLOOD & CANCER, 2023, 70 (12)
  • [50] Prognostic prediction of the platelet-to-lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis
    Li, De-Zhao
    Guo, Jia
    Song, Qing-Kun
    Hu, Xiang-Jin
    Bao, Xu-Li
    Lu, Jun
    TRANSLATIONAL CANCER RESEARCH, 2022, 11 (11) : 4037 - +
12345